Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and their cardiovascular benefits—The role of the GLP‐1 receptor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and their cardiovascular benefits—The role of the GLP‐1 receptor

Published:2021-05-06 Issue:4 Volume:179 Page:659-676
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British J Pharmacology

Author:

Helmstädter Johanna¹,Keppeler Karin¹,Küster Leonie¹,Münzel Thomas¹²³,Daiber Andreas¹²³^ORCID,Steven Sebastian¹²^ORCID

Affiliation:

1. Department of Cardiology University Medical Centre of the Johannes Gutenberg University Mainz Germany

2. Center of Thrombosis and Hemostasis (CTH) University Medical Center Mainz Germany

3. Partner Site Rhine‐Main German Center for Cardiovascular Research (DZHK) Mainz Germany

Funder

Bundesministerium für Bildung und Forschung

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15462

Reference143 articles.

1. The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors;Alexander S. P. H.;British Journal of Pharmacology,2019

2. The GLP-1 Receptor Agonist Liraglutide Increases Myocardial Glucose Oxidation Rates via Indirect Mechanisms and Mitigates Experimental Diabetic Cardiomyopathy

3. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020

4. Glucagon-like peptide 1 in health and disease

5. Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Portulaca oleracea (purslane) aqueous extract reduced the adverse metabolic outcomes and favored liraglutide activities in streptozotocin-induced cardiometabolic disorders of male Wistar rats;Endocrine and Metabolic Science;2024-09

2. A Very Rare Cause of Markedly Elevated CA 19-9: Glucagon-like Peptide-1 Receptor Agonists;Diabetes & Metabolism;2024-09

3. Mechanistic Pathways and Clinical Implications of GLP-1 Receptor Agonists in Type 1 Diabetes Management;International Journal of Molecular Sciences;2024-08-29

4. Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs;Journal of Clinical Medicine;2024-08-09

5. New insights into the roles of Irisin in diabetic cardiomyopathy and vascular diseases;Biomedicine & Pharmacotherapy;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3